NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 08 July 2019 |
| Author/s |
author: Herbert Loong Axel Le Cesne Sylvie Bonvalot Angel Montero Piotr Rutkowski Marco Rastrelli Peter Hohenberger Víctor Moreno Marie-Pierre Sunyach |
| Publication date | July 8, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |